Medical Journals

Deficiency of Tnfr1 Protects Myocardium Through Socs3 and Il-6 but Not P38 Mapk or Il-1beta.

Authors:
  • Wang Meijing
  • Markel Troy
  • Crisostomo Paul
  • Herring Christine
  • Meldrum Kirstan K
  • Lillemoe Keith D
  • Meldrum Daniel R

From: Departments of Surgery, Indiana University School of Medicine, Indianapolis, Indiana, USA.

American journal of physiology. Heart and circulatory physiology

  • Publish Date: Apr 2007
  • ISSN: 0363-6135
  • Volume: 292
  • Issue: 4
  • Pages: H1694-9
  • Medium: Print
  • Language: English
  • Citation (JAMA): Wang Meijing, Markel Troy, Crisostomo Paul, et al. Deficiency of Tnfr1 Protects Myocardium Through Socs3 and Il-6 but Not P38 Mapk or Il-1beta.. Am. J. Physiol. Heart Circ. Physiol. Apr 2007;292:H1694-9

Abstract

Tumor necrosis factor-alpha (TNF-alpha) plays an important role in the development of heart failure. There is a direct correlation between myocardial function and myocardial TNF levels in humans. TNF may induce local inflammation to exert tissue injury. On the other hand, suppressors of cytokine signaling (SOCS) proteins have been shown to inhibit proinflammatory signaling. However, it is unknown whether TNF mediates myocardial inflammation via STAT3/SOCS3 signaling in the heart and, if so, whether this effect is through the type 1 55-kDa TNF receptor (TNFR1). We hypothesized that TNFR1 deficiency protects myocardial function and decreases myocardial IL-6 production via the STAT3/SOCS3 pathway in response to TNF. Isolated male mouse hearts (n = 4/group) from wild-type (WT) and TNFR1 knockout (TNFR1KO) were subjected to direct TNF infusion (500 pg.ml(-1).min(-1) x 30 min) while left ventricular developed pressure and maximal positive and negative values of the first derivative of pressure were continuously recorded. Heart tissue was analyzed for active forms of STAT3, p38, SOCS3 and SOCS1 (Western blot analysis), as well as IL-1beta and IL-6 (ELISA). Coronary effluent was analyzed for lactate dehydrogenase (LDH) activity. As a result, TNFR1KO had significantly better myocardial function, less myocardial LDH release, and greater expression of SOCS3 (percentage of SOCS3/GAPDH: 45 +/- 4.5% vs. WT 22 +/- 6.5%) after TNF infusion. TNFR1 deficiency decreased STAT3 activation (percentage of phospho-STAT3/STAT3: 29 +/- 6.4% vs. WT 45 +/- 8.8%). IL-6 was decreased in TNFR1KO (150.2 +/- 3.65 pg/mg protein) versus WT (211.4 +/- 26.08) mice. TNFR1 deficiency did not change expression of p38 and IL-1beta following TNF infusion. These results suggest that deficiency of TNFR1 protects myocardium through SOCS3 and IL-6 but not p38 MAPK or IL-1beta.

Mesh Headings (Keywords): Animals, Heart, Interleukin-1beta, Interleukin-6, Male, Mice, Mice, Knockout, Myocarditis, Myocardium, Receptors, Tumor Necrosis Factor, Type I, Reperfusion Injury, STAT3 Transcription Factor, Signal Transduction, Suppressor of Cytokine Signaling Proteins, Tumor Necrosis Factor-alpha, p38 Mitogen-Activated Protein Kinases


Check for Full Text / PubMed Unique Identifier (PMID): 17114246


This abstract is part of PubMed, a service of the U.S. National Library of Medicine. PubMed includes more than 17 million citations from MEDLINE and other life science journals for biomedical articles. See Copyright and Disclaimers.

Linked medical terms appearing on this page are added by Healia to help readers find more information and are not part of the original PubMed document.

The data herein was last updated on July 8th, 2008 and may not reflect the most current and accurate data available from NLM.


Advertisements

About | Privacy Policy | Business Solutions | Advertise | Contact | Add Healia to your site

©2012. Healia / Meredith Corporation  

Use of this site constitutes acceptance of our Terms of Service and Privacy Policy. All content on this Web site, including medical opinion and any other health-related information, is for informational purposes only and should not be used for a specific diagnosis or individual treatment plan for any situation. Use of this site and the information contained herein does not create a doctor-patient relationship. Always seek the direct advice of your doctor in connection with any questions or issues you may have regarding your own health or the health of others.